|
IE37913B1
(en)
|
1972-08-02 |
1977-11-09 |
Bioresearch Sas |
Salt of s-adenosyl-l-methionine
|
|
IE39517B1
(en)
|
1973-06-27 |
1978-10-25 |
Bioresearch Sas |
Double salts of s-adenosyl-l-methhionine
|
|
AR221676A1
(es)
|
1974-07-12 |
1981-03-13 |
Bioresearch Sas |
Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
|
|
US5264446A
(en)
|
1980-09-09 |
1993-11-23 |
Bayer Aktiengesellschaft |
Solid medicament formulations containing nifedipine, and processes for their preparation
|
|
US4525345A
(en)
|
1981-12-24 |
1985-06-25 |
Verex Laboratories, Inc. |
Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
|
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
|
US4556678A
(en)
|
1982-06-24 |
1985-12-03 |
Key Pharmaceuticals, Inc. |
Sustained release propranolol tablet
|
|
DE3435325A1
(de)
|
1983-04-09 |
1986-04-17 |
Nikken Chemicals Co., Ltd., Tokio/Tokyo |
Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
|
|
IT1169772B
(it)
|
1983-08-24 |
1987-06-03 |
Bioresearch Spa |
Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
|
|
US4680323A
(en)
|
1983-12-01 |
1987-07-14 |
Hans Lowey |
Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
|
|
US4537772A
(en)
|
1984-05-02 |
1985-08-27 |
Merck & Co., Inc. |
Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
|
|
IT1173992B
(it)
|
1984-05-16 |
1987-06-24 |
Bioresearch Spa |
Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
|
|
US4601894A
(en)
|
1985-03-29 |
1986-07-22 |
Schering Corporation |
Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
|
|
US4695591A
(en)
|
1985-03-29 |
1987-09-22 |
Schering Corporation |
Controlled release dosage forms comprising hydroxypropylmethylcellulose
|
|
US4687757A
(en)
|
1986-03-24 |
1987-08-18 |
Phillips Petroleum Company |
Hydrofining catalyst composition and process for its preparation
|
|
US4756911A
(en)
|
1986-04-16 |
1988-07-12 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US5200193A
(en)
|
1987-04-22 |
1993-04-06 |
Mcneilab, Inc. |
Pharmaceutical sustained release matrix and process
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
US5073380A
(en)
|
1987-07-27 |
1991-12-17 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
|
FR2623396B1
(fr)
|
1987-11-25 |
1990-03-30 |
Sanofi Sa |
Utilisation de l'ademetionine contre le vieillissement de la peau
|
|
US5169642A
(en)
|
1988-06-24 |
1992-12-08 |
Abbott Laboratories |
Sustained-release drug dosage units
|
|
GB8900812D0
(en)
*
|
1989-01-14 |
1989-03-08 |
Univ Manchester |
Pharmaceutical method and compositions
|
|
IT1229477B
(it)
|
1989-03-13 |
1991-09-03 |
Bioresearch Spa |
Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative
|
|
US5137712A
(en)
|
1990-08-31 |
1992-08-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of s-adenosyl-l-methionine (SAMe) to reverse and/or prevent supersensitivity, tolerance and extrapyramidal side effects induced by neuroleptic treatment
|
|
IT1243859B
(it)
|
1990-10-23 |
1994-06-28 |
Bioresearch Spa |
Composizioni farmaceutiche comprendenti associazioni fra sali di s-adenosil-l-metionina e acido 5-metil (o 5-formil)-tetraidrofolico per la terapia di complicanze neurologiche negli ammalati di aids.
|
|
US5543154A
(en)
|
1991-12-27 |
1996-08-06 |
Merck & Co., Inc. |
Controlled release nifedipine delivery device
|
|
IL104192A
(en)
|
1992-02-17 |
1998-01-04 |
Siegfried Ag Pharma |
Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
|
|
JPH05271067A
(ja)
|
1992-03-24 |
1993-10-19 |
Takeda Chem Ind Ltd |
線維化抑制剤
|
|
US8178516B2
(en)
|
1992-06-30 |
2012-05-15 |
Sylvan Labs, LLC |
Compositions and method for treatment of chronic inflammatory diseases
|
|
RU2018314C1
(ru)
*
|
1993-07-15 |
1994-08-30 |
Приморское научное медико-техническое общество |
Средство для лечения экземы
|
|
AU721067B2
(en)
|
1995-04-25 |
2000-06-22 |
Oridigm Corporation |
S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
|
|
DE19631085A1
(de)
|
1996-08-01 |
1998-02-05 |
Basf Ag |
Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut
|
|
DE19631084A1
(de)
|
1996-08-01 |
1998-02-05 |
Basf Ag |
Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
|
|
US5877935A
(en)
|
1996-09-17 |
1999-03-02 |
Honda Giken Kogyo Kabushiki-Kaisha |
Active carbon used for electrode for organic solvent type electric double layer capacitor
|
|
US5962522A
(en)
*
|
1997-09-05 |
1999-10-05 |
Avmax, Inc. |
Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
|
|
US6180666B1
(en)
|
1997-09-05 |
2001-01-30 |
Anmax, Inc. |
Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
|
|
US5922341A
(en)
|
1997-10-28 |
1999-07-13 |
Vivus, Incorporated |
Local administration of pharmacologically active agents to treat premature ejaculation
|
|
WO1999043336A1
(en)
|
1998-02-27 |
1999-09-02 |
Nutramax Laboratories, Inc. |
L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
|
|
US6365185B1
(en)
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
US7906153B2
(en)
|
1998-04-08 |
2011-03-15 |
Theta Biomedical Consulting & Development Co., Inc. |
Anti-inflammatory compositions for treating multiple sclerosis
|
|
US7060479B2
(en)
|
1999-12-08 |
2006-06-13 |
Serono Genetics Institute, S.A. |
Full-length human cDNAs encoding potentially secreted proteins
|
|
DE19839443A1
(de)
|
1998-08-29 |
2000-03-02 |
Miklos Ghyczy |
Arnzneimittel mit entzündungshemmender Wirkung
|
|
EP1027885B1
(en)
|
1999-02-09 |
2008-07-09 |
Pfizer Products Inc. |
Basic drug compositions with enhanced bioavailability
|
|
EP1027887B1
(en)
|
1999-02-10 |
2008-08-13 |
Pfizer Products Inc. |
Matrix controlled release device
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US6635615B1
(en)
|
1999-11-17 |
2003-10-21 |
Rolland F. Hebert |
Stable salts of S-adenosyl-l-methionine
|
|
US6685928B2
(en)
|
1999-12-07 |
2004-02-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions and methods
|
|
CA2405360A1
(en)
|
2000-04-07 |
2001-10-18 |
The Board Of Regents Of The University Of Texas System |
Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity
|
|
US6944766B2
(en)
|
2000-05-02 |
2005-09-13 |
Canon Kabushiki Kaisha |
Information processing apparatus
|
|
FI113942B
(fi)
*
|
2000-08-18 |
2004-07-15 |
Control Ox Oy |
Kasviperäisten fenolisten yhdisteiden käyttö valmistettaessa klamydiainfektion hoidossa ja ennaltaehkäisyssä käyttökelpoista farmaseuttista valmistetta, terveyteen myönteisesti vaikuttavaa ravintoainekoostumusta tai koostumusta lisättäväksi tällaisiin elintarvikkeisiin
|
|
GB2368792A
(en)
|
2000-10-06 |
2002-05-15 |
Roger Randal Charles New |
Absorption enhancers
|
|
AU2002228321A1
(en)
|
2000-12-18 |
2002-07-01 |
Orchid Chemicals And Pharmaceuticals Limited |
A novel soft-gelatin capsule comprising s-adenosylmethionine and a method for producing the same
|
|
US6759395B2
(en)
|
2000-12-18 |
2004-07-06 |
Orchid Chemicals & Pharmaceuticals, Ltd. |
Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
|
|
GB0109428D0
(en)
|
2001-04-17 |
2001-06-06 |
Process & Ind Design Consultan |
Therapeutic compositions
|
|
GB0111579D0
(en)
|
2001-05-11 |
2001-07-04 |
Holford & Associates Ltd |
Oral supplement
|
|
JP3908513B2
(ja)
|
2001-11-19 |
2007-04-25 |
日本甜菜製糖株式会社 |
肝機能改善剤
|
|
WO2004000280A1
(en)
|
2002-04-29 |
2003-12-31 |
Shire Laboraties, Inc. |
Pharmaceutical formulations with improved bioavailability
|
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
GB0308732D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
|
GB0308734D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
|
US20050158382A1
(en)
|
2003-09-26 |
2005-07-21 |
Evangeline Cruz |
Controlled release formulations of opioid and nonopioid analgesics
|
|
JP5069001B2
(ja)
|
2003-10-10 |
2012-11-07 |
ベロクシス ファーマシューティカルズ エー／エス |
フィブラートを含む固体投与形態
|
|
WO2005041926A1
(en)
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
|
|
EP1701705A4
(en)
|
2003-12-24 |
2007-08-08 |
Advancis Pharmaceutical Corp |
IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
|
|
WO2005065661A2
(en)
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Immediate, controlled and sustained release formulations of galanthamine
|
|
US7429569B2
(en)
|
2004-01-29 |
2008-09-30 |
Fast Balance, Inc. |
Compositions and methods for the regulation of homocysteine levels within the body
|
|
US20050181047A1
(en)
|
2004-02-18 |
2005-08-18 |
Jaime Romero |
Compositions and methods for timed release of water-soluble nutritional supplements
|
|
US8263574B2
(en)
|
2004-09-29 |
2012-09-11 |
James L. Schaller, P.A. |
Topical formulations for the treatment of depression with S adenosyl methionine
|
|
WO2006044202A2
(en)
|
2004-10-19 |
2006-04-27 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
|
|
US20060127506A1
(en)
|
2004-12-10 |
2006-06-15 |
Hebert Rolland F |
Compositions of S-adenosyl-L-methionine
|
|
US20060280789A1
(en)
|
2004-12-27 |
2006-12-14 |
Eisai Research Institute |
Sustained release formulations
|
|
US8063024B2
(en)
|
2005-01-26 |
2011-11-22 |
University Of Manitoba |
Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
|
|
DE102005024614A1
(de)
|
2005-05-25 |
2006-11-30 |
Röhm Gmbh |
Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
|
|
DK1731596T5
(da)
|
2005-06-09 |
2013-09-23 |
Gnosis Spa |
Tørrede, frysetørrede og/eller mikroindkapslede celler af Saccharomyces cerevisiae med et højt indhold af (S)-(+)-S-adenosyl-L-methionin
|
|
EP1896002A4
(en)
|
2005-06-27 |
2009-11-25 |
Biovail Lab Int Srl |
BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
|
|
BRPI0707616A2
(pt)
|
2006-02-09 |
2011-05-10 |
Alba Therapuetics Corp |
formulaÇÕes para um efetor de junÇço oclusiva
|
|
AR059423A1
(es)
|
2006-02-09 |
2008-04-09 |
Univ Maryland |
Administracion oral de agentes terapeuticos usando agonistas de uniones impermeables
|
|
GB0603252D0
(en)
|
2006-02-17 |
2006-03-29 |
Axcess Ltd |
Dissolution aids for oral peptide delivery
|
|
ITMI20060629A1
(it)
|
2006-03-31 |
2007-10-01 |
Daniele Giovannone |
Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
|
|
US20070265211A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Matthias Rath |
Novel composition and method effective in inhibiting the atherogenic process
|
|
EP2040696B1
(en)
|
2006-07-14 |
2017-01-25 |
DSM IP Assets B.V. |
Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
|
|
US20100062073A1
(en)
|
2006-11-29 |
2010-03-11 |
Ronald Arthur Beyerinck |
Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
|
|
CN101636156B
(zh)
|
2006-12-28 |
2012-05-02 |
株式会社微生物科技 |
没食子酸烷基酯的药物组合物
|
|
US20090197824A1
(en)
|
2008-01-31 |
2009-08-06 |
Methylation Sciences International Srl |
Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
|
|
US20090088404A1
(en)
|
2007-01-31 |
2009-04-02 |
Methylation Sciences International Srl |
Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
|
|
US20080206333A1
(en)
|
2007-01-31 |
2008-08-28 |
Methylation Sciences International Srl |
Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
|
|
CN101012336A
(zh)
*
|
2007-01-31 |
2007-08-08 |
浙江大学 |
含植物油的高强度可降解谷类蛋白质塑料及其制备方法
|
|
US20080279931A1
(en)
|
2007-05-09 |
2008-11-13 |
Northern Holdings Inc. |
Composition for treatment of pain
|
|
ITMI20081405A1
(it)
|
2008-07-29 |
2010-01-30 |
Velleja Res Srl |
Formulazioni orali istantanee, gelificanti a temperatura ambiente, utili per contrastare il deperimento organico e la sindrome depressiva connessi a cachessia, anoressia, malattia metabolica, malattia endocrina e disfagia
|
|
WO2010012109A1
(en)
|
2008-08-01 |
2010-02-04 |
Volkovs |
System and method for the calculation of a polynomial-based hash function and the erindale-plus hashing algorithm
|
|
WO2010027014A1
(ja)
|
2008-09-04 |
2010-03-11 |
株式会社カネカ |
Ｓ－アデノシル－ｌ－メチオニンの吸収性を高める方法およびｓ－アデノシル－ｌ－メチオニンの吸収性が高められた組成物
|
|
EP2193787A1
(en)
|
2008-12-02 |
2010-06-09 |
Giorgio Stramentinoli |
Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use
|
|
WO2012012902A1
(en)
*
|
2010-07-28 |
2012-02-02 |
Msi Methylation Sciences Inc. |
S-adenosylmethionine formulations with enhanced bioavailability
|
|
US20110027342A1
(en)
|
2009-07-28 |
2011-02-03 |
Msi Methylation Sciences, Inc. |
S-adenosylmethionine formulations with enhanced bioavailability
|
|
US8329208B2
(en)
|
2009-07-28 |
2012-12-11 |
Methylation Sciences International Srl |
Pharmacokinetics of S-adenosylmethionine formulations
|
|
US20110064720A1
(en)
|
2009-09-16 |
2011-03-17 |
Daniel Moses Amato |
Dietary Supplement Compositions and Methods of Making and Using the Same
|
|
WO2012170488A1
(en)
|
2011-06-07 |
2012-12-13 |
Zx Pharma, Llc |
Multiparticulate s-adenosylmethionine compositions and related methods
|
|
CA2888302C
(en)
|
2012-10-17 |
2016-05-31 |
Methylation Sciences International Srl |
Compositions comprising s-adenosylmethionine and a gallic acid ester
|
|
WO2014089174A2
(en)
|
2012-12-06 |
2014-06-12 |
Aerodesigns, Inc. |
Aerosol dispenser with edible cartridge
|
|
US20150087679A1
(en)
|
2013-09-20 |
2015-03-26 |
Hany Helmi |
Nutritional sleep supplement
|
|
US20170027976A1
(en)
|
2014-04-14 |
2017-02-02 |
Methylation Sciences International Srl |
Novel ademetionine formulations
|
|
EA201692060A1
(ru)
|
2014-04-14 |
2017-02-28 |
Флекс Фарма, Инк. |
Активаторы ионного канала и способы их применения
|
|
JP2015214518A
(ja)
|
2014-05-12 |
2015-12-03 |
ライオン株式会社 |
睡眠の質を改善する方法及び睡眠の質の改善用の経口用組成物
|
|
US20180000881A1
(en)
|
2015-01-22 |
2018-01-04 |
Bob Fritz |
Phosphatidylserine-Containing Diet Supplement Aids With Melatonin Anti-Catabolic Dietary Nutrients
|
|
RU2587331C1
(ru)
|
2015-06-19 |
2016-06-20 |
Общество с ограниченной ответственностью "Полигепазол" |
Способ получения фармацевтической композиции адеметионина и его лекарственной формы
|
|
CN105232515A
(zh)
|
2015-10-10 |
2016-01-13 |
齐齐哈尔医学院 |
没食子酸乙酯用于制备治疗人结肠癌凋亡药物的应用
|
|
US10449148B2
(en)
|
2015-11-04 |
2019-10-22 |
Braingear Enterprises, Inc. |
Dietary supplement for improving brain health
|
|
CN105476982A
(zh)
|
2016-02-02 |
2016-04-13 |
张干 |
没食子酸的新用途
|
|
US20200246404A1
(en)
|
2017-02-15 |
2020-08-06 |
Molecular Infusions, Llc |
Formulations
|
|
CN108853085A
(zh)
|
2017-05-15 |
2018-11-23 |
苏州凯祥生物科技有限公司 |
儿茶素类和表儿茶素类化合物用于上调MicroRNA-126表达水平的用途
|
|
WO2019010254A1
(en)
|
2017-07-07 |
2019-01-10 |
President And Fellows Of Harvard College |
METHOD OF TREATING A DAMAGE INDUCED BY SLEEP
|
|
CN111265509A
(zh)
|
2020-02-19 |
2020-06-12 |
齐鲁工业大学 |
没食子酸衍生物防治动脉粥样硬化疾病的应用
|
|
AU2024274445A1
(en)
|
2023-05-15 |
2025-11-27 |
Bonafide Health, Llc |
Sleep-improving compositions and methods of use
|